ITGR•November 17, 2026 at 1:59 PM UTCHealth Care Equipment & Services

KKR Completes $5.7B Acquisition of Integer Holdings

Read source article

What happened

Integer Holdings Corporation announced the completion of its acquisition by an affiliate of KKR in a transaction valued at approximately $5.7 billion enterprise value. The deal, first announced on August 3, 2026, received stockholder approval on October 21, 2026, and closed on November 17, 2026. Previously, Integer was a leading medical device CDMO with strong fundamentals but traded at a full valuation of ~30x P/E and ~58x EV/EBITDA, prompting a HOLD rating in our prior analysis. The acquisition takes the company private, meaning ITGR shares will cease trading on the NYSE and stockholders will receive the merger consideration as per the agreement. The transaction positions Integer to advance innovation and growth under private ownership, free from quarterly public market pressures.

Implication

The completion of the KKR acquisition resolves the prior HOLD valuation debate, as the buyout price reflects a premium to the previously observed market capitalization. Investors who held ITGR shares should confirm the final merger consideration and any tax implications, but the investment case is now concluded. For those who were waiting for a better entry point, the opportunity is gone; the company will no longer be publicly traded. Under KKR's ownership, Integer may pursue longer-term strategic initiatives without the scrutiny of quarterly earnings, potentially accelerating growth in its CDMO business. However, public investors cannot participate in that upside; the focus now shifts to how KKR manages the company's debt and growth trajectory post-acquisition.

Thesis delta

The prior HOLD thesis on ITGR was based on public market valuation and near-term headwinds. The completion of the KKR acquisition at $5.7 billion enterprise value supersedes that thesis, as the stock is being taken private at a premium. There is no longer a public equity investment thesis; existing shareholders should accept the merger consideration and move on.

Confidence

High